Blankenbaker W L, DiFazio C A, Berry F A
Anesthesiology. 1975 Mar;42(3):325-30. doi: 10.1097/00000542-197503000-00016.
Concentrations of lidocaine and its metabolites were measured chromatographically in the blood and urine of mothers and babies after epidural administration of lidocaine to the mother for cesarean delivery. Delivery occurred a mean time of 29.83 plus or minus 8.64 minutes after a mean dose of 398.33 plus or minus 63.38 mg to the mother, at which time mean maternal venous plasma concentration was 1.70 plus or minus 0.77 mug/ml. Of the total molar quantity of lidocaine and metabolite recovered from the newborns' urine in the first 12 hours of life, 50.63 per cent appeared as unchanged lidocaine, while 49.37 per cent appeared as metabolites. In the second 12 hours of life, 23.37 per cent appeared as unchanged lidocaine, while 76.63 per cent appeared as metabolites. We conclude that the greater proportion of metabolite excretion in the second 12 hours is evidence that the new born is capable of metabolizing lidocaine.
对行剖宫产术的母亲硬膜外注射利多卡因后,检测母亲和婴儿血液及尿液中利多卡因及其代谢物的色谱浓度。母亲平均剂量为398.33±63.38mg后,平均29.83±8.64分钟分娩,此时母亲静脉血浆平均浓度为1.70±0.77μg/ml。在新生儿出生后12小时内从其尿液中回收的利多卡因和代谢物的总摩尔量中,50.63%为未变化的利多卡因,49.37%为代谢物。在出生后的第二个12小时内,23.37%为未变化的利多卡因,76.63%为代谢物。我们得出结论,出生后第二个12小时代谢物排泄比例更高,这证明新生儿有能力代谢利多卡因。